T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$7.49B |
| 2 |
Micron Technology
MU
|
+$6.62B |
| 3 |
Lam Research
LRCX
|
+$3.45B |
| 4 |
Applied Materials
AMAT
|
+$3.03B |
| 5 |
Advanced Micro Devices
AMD
|
+$2.91B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$12.1B |
| 2 |
Apple
AAPL
|
+$11.6B |
| 3 |
Amazon
AMZN
|
+$3.54B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$3.07B |
| 5 |
Keysight
KEYS
|
+$1.82B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.73% |
| 2 | Healthcare | 11.3% |
| 3 | Financials | 10.32% |
| 4 | Communication Services | 9.66% |
| 5 | Industrials | 9.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1951
Warner Music
WMG
$14.3B
| $2.21M | ﹤0.01% |
81,474
+11,649
| +17% | +$346K |
|
1952
National Vision
EYE
$1.27B
| $2.19M | ﹤0.01% |
115,331
+17,090
| +17% | +$348K |
|
1953
The Greenbrier Companies
GBX
$1.31B
| $2.19M | ﹤0.01% |
44,633
+8,032
| +22% | +$395K |
|
1954
AnaptysBio
ANAB
$1.53B
| $2.19M | ﹤0.01% |
32,374
+2,683
| +9% | +$163K |
|
1955
BellRing Brands
BRBR
$909M
| $2.19M | ﹤0.01% |
168,810
+49,999
| +42% | +$603K |
|
1956
NovoCure
NVCR
$1.84B
| $2.18M | ﹤0.01% |
143,949
+28,847
| +25% | +$436K |
|
1957
Ducommun
DCO
$2.55B
| $2.17M | ﹤0.01% |
11,718
+1,535
| +15% | +$228K |
|
1958
ManpowerGroup
MAN
$2.66B
| $2.17M | ﹤0.01% |
64,135
+18,884
| +42% | +$578K |
|
1959
Novavax
NVAX
$1.74B
| $2.16M | ﹤0.01% |
229,193
+48,725
| +27% | +$437K |
|
1960
Harmony Biosciences
HRMY
$2.33B
| $2.14M | ﹤0.01% |
58,865
+11,151
| +23% | +$352K |
|
1961
TriNet
TNET
$2.96B
| $2.14M | ﹤0.01% |
43,282
+6,045
| +16% | +$259K |
|
1962
Pennant Group
PNTG
$1.43B
| $2.14M | ﹤0.01% |
57,846
+9,403
| +19% | +$307K |
|
1963
Arlo Technologies
ARLO
$1.35B
| $2.14M | ﹤0.01% |
158,402
+34,339
| +28% | +$465K |
|
1964
Diageo
DEO
$47.9B
| $2.13M | ﹤0.01% |
26,543
+11,805
| +80% | +$953K |
|
1965
XPEL
XPEL
$1.19B
| $2.13M | ﹤0.01% |
42,992
+6,036
| +16% | +$275K |
|
1966
Yelp
YELP
$947M
| $2.13M | ﹤0.01% |
86,870
+10,183
| +13% | +$254K |
|
1967
Personalis
PSNL
$1.75B
| $2.13M | ﹤0.01% |
158,838
-1,491,303
| -90% | -$12.1M |
|
1968
TripAdvisor
TRIP
$973M
| $2.13M | ﹤0.01% |
154,940
+23,065
| +17% | +$261K |
|
1969
Surgery Partners
SGRY
$1.91B
| $2.12M | ﹤0.01% |
126,064
+27,650
| +28% | +$388K |
|
1970
Park Aerospace
PKE
$653M
| $2.12M | ﹤0.01% |
55,475
+9,380
| +20% | +$312K |
|
|
AVNS
1971
DELISTED
Avanos Medical
AVNS
| $2.11M | ﹤0.01% |
84,938
+14,393
| +20% | +$337K |
|
1972
Xeris Biopharma Holdings
XERS
$1.78B
| $2.11M | ﹤0.01% |
266,877
+57,843
| +28% | +$369K |
|
1973
Adient
ADNT
$1.34B
| $2.11M | ﹤0.01% |
114,939
+12,416
| +12% | +$265K |
|
1974
O-I Glass
OI
$897M
| $2.11M | ﹤0.01% |
219,220
+28,654
| +15% | +$270K |
|
1975
Middlesex Water
MSEX
$989M
| $2.1M | ﹤0.01% |
37,436
+5,626
| +18% | +$296K |
|
Similar funds
T. Rowe Price Associates's Q2 2026 Portfolio in Review
As of Q2 2026, T. Rowe Price Associates held 3,356 positions worth $999B, up 16% from $865B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
T. Rowe Price Associates's Q2 2026 filing shows 224 new, 2,237 increased, 645 reduced and 116 closed positions. Its largest new stake was SpaceX: 10,709,016 shares worth $1.83B. The largest sale was Microsoft, an estimated $12.1B.
By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 34% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q2 2026 buy was SpaceX: 10,709,016 shares worth $1.83B.
- T. Rowe Price Associates added most to Alphabet (Google) Class A in Q2 2026, an estimated $7.49B increase.
- T. Rowe Price Associates's biggest Q2 2026 reduction was Microsoft, cutting an estimated $12.1B.
- T. Rowe Price Associates fully exited Sibanye-Stillwater in Q2 2026, selling an estimated $40.4M.
- T. Rowe Price Associates's ten largest holdings make up 32% of its $999B portfolio in Q2 2026.
- T. Rowe Price Associates opened 224 new positions and closed 116 in Q2 2026.
- T. Rowe Price Associates's portfolio value rose 16% quarter-over-quarter to $999B.
Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.